Adventures in eMarketing


	Trouble viewing this email? Open it as a webpage

Hello %%First Name%%,

We agree with Med Ad News that 2011 is going to be the Year of the Empowered Patient. Siren’s founder and president Wendy White was quoted in the article, talking about the importance of entering into a relationship with patients based on trust and authenticity.

2011 will also continue the pharmaceutical industry’s exploration of social media. The FDA may, or may not, come out with guidance this year, but smart pharmaceutical companies are already taking advantage of the most important part of social media: listening to the conversation. Pharma marketers can safely listen and learn from the conversations going on around their brand.

As smartphones gain wider adoption, mobile marketing, including health applications, will play an increasing role. We look forward to an exciting year!

Top SirenSong Blog Entries

•	Pharma Marketers Should Pay Attention to Nurses Are nurses part of your marketing strategy? Find out how they’re become increasingly influential in patient decisions.
•	Consumers Don’t Trust Pharma, So What Can We Do? Some think more regulation will build trust. However, learn about another way pharma can regain the trust of consumers.
•	What Do You Think Makes a Successful Pharmaceutical Blog? Website traffic? Number of comments? Read about measuring the success of pharma blogs.
•	Pharma Marketing Tweetchat Celebrates 1st Anniversary The weekly pharma marketing and social media tweetchat – #SocPharm – has turned one-year-old! Read more about its successes over the past year and plans for the future.
•	Why is Pepsi Giving Away $20M? The Value of Cause Marketing Learn how some pharmaceutical companies are successfully collaborating with nonprofits on cause marketing campaigns.

Siren News

Eileen O’Brien Named to Board of Directors of the Greater Philadelphia Chapter of HBA Director of search and innovation at Siren Interactive, Eileen O’Brien, was among the six women recently elected to the Board of Directors of the Greater Philadelphia Chapter of the Healthcare Businesswomen’s Association.

MY READING LIST

•	Pfizer Canada Shares its Social Media Response Flow Chart Marketing 4 Health
•	Drug Companies Take Their Pitch to Social Media Time Magazine
•	iPads are Latest Weapon in Medical Sales eMarketer
•	Mobile Health Applications Could Triple by 2012 Fierce Mobile Health
•	From Ads to Apps Medical Marketing & Media
•	At Work, Sermo Docs Prefer the Epocrates App, MM&M Poll Finds Medical Marketing & Media
•	Marketing to Mom Med Ad News
•	Coupons for Patients But Higher Bills for Insurers New York Times
•	Facebook Passes Google as Most Visited Site of 2010 Computerworld
•	Agenda 2011: On the Pharma Radar Med Ad News

Siren in the Media

Siren’s founder and president, Wendy White, was featured in the January’s Med Ad News in the article Agenda 2011: On the Pharma Radar talking about the move towards personalized medicine. White was also quoted about the importance of caregivers and shared her personal insights in the article, Marketing to Mom.

An in-depth interview with White, A Personal Connection, on PharmaLive.com details Siren’s transition to a focus on rare disorder therapies.

Research Insight:
Patients Want More Information From Doctors

A research study found physicians are not doing enough to educate patients about disease management. The survey found 95% were looking for more comprehensive information about disease management, and 77% said they hadn't received any written information about their illness or medications directly from the physician.


Patients surveyed said specific types of information are “very much” or “extremely” valuable, including:
• Details on the importance of follow-ups and tests	94%
• Dietary recommendations based on condition	86%
• Online resources to help manage a condition	84%
• Changes in lifestyle that might be required	82%
• Information on medications and potential side effects	78%

The online sample of 7,028 respondents was conducted in September 2010, with a margin of error of plus or minus 0.94%, for MedTera.


	This email was sent by: %%Member_Busname%% %%Member_Addr%% %%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%% Forward to a Friend \| Update Profile \| Unsubscribe \| Privacy Policy